Search

everythinglearnresearchcommunity

for

Search:↓

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Melatonin helps hair growth in women with hair loss.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Low iron and vitamin D levels are linked to hair loss in women.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Testosterone may slow down wound healing and increase inflammation.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Higher iron levels in the blood are not linked to increased hair loss in women.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

Melatonin solution helps treat hair loss in men and women.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Using steroids can increase the risk of heart problems.